Cardiac conduction disorders in young adults: clinical characteristics and genetic background of an underestimated population.

cardiac conduction disorders pacemaker young

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
09 Mar 2024
Historique:
received: 09 01 2024
revised: 04 03 2024
accepted: 05 03 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 11 3 2024
Statut: aheadofprint

Résumé

Cardiac conduction disorders (CCD) in patients <50 years are a rare and mostly unknown condition. We aimed to assess clinical characteristics and genetic background of patients < 50 years with CCD of unknown origin. We retrospectively review a consecutive series of patients with a diagnosis of CCD before the age of 50 referred to our Centre between January 2019 and December 2021. Patients underwent complete clinical examination and genetic evaluation. We enrolled 39 patients with a median age of 40 years (28-47 years) at the onset of symptoms. A cardiac implantable device (CIED) was implanted in 69% of the patients. In 15 out of 39 CCD index patients (38%), we found a total of 13 different gene variations (3 pathogenic, 6 likely pathogenic and 4 variants of uncertain significance), occurring mostly in three genes (SCN5A, TRPM4 and LMNA). In our cohort, genetic testing leads to the decision to implant an ICD in two patients for the increased risk of SCD. Patients with the occurrence of CCD before the age of 50 present a high rate of pathologic gene variations, occurring mostly in three genes (SCN5A, TRPM4 and LMNA). The presence of pathogenic variations may add information regarding the prognosis and lead to an individualized therapeutic approach.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac conduction disorders (CCD) in patients <50 years are a rare and mostly unknown condition.
OBJECTIVE OBJECTIVE
We aimed to assess clinical characteristics and genetic background of patients < 50 years with CCD of unknown origin.
METHODS METHODS
We retrospectively review a consecutive series of patients with a diagnosis of CCD before the age of 50 referred to our Centre between January 2019 and December 2021. Patients underwent complete clinical examination and genetic evaluation.
RESULTS RESULTS
We enrolled 39 patients with a median age of 40 years (28-47 years) at the onset of symptoms. A cardiac implantable device (CIED) was implanted in 69% of the patients. In 15 out of 39 CCD index patients (38%), we found a total of 13 different gene variations (3 pathogenic, 6 likely pathogenic and 4 variants of uncertain significance), occurring mostly in three genes (SCN5A, TRPM4 and LMNA). In our cohort, genetic testing leads to the decision to implant an ICD in two patients for the increased risk of SCD.
CONCLUSIONS CONCLUSIONS
Patients with the occurrence of CCD before the age of 50 present a high rate of pathologic gene variations, occurring mostly in three genes (SCN5A, TRPM4 and LMNA). The presence of pathogenic variations may add information regarding the prognosis and lead to an individualized therapeutic approach.

Identifiants

pubmed: 38467355
pii: S1547-5271(24)00243-1
doi: 10.1016/j.hrthm.2024.03.008
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Classifications MeSH